HLN:NYSE
Haleon PLC - ADR
$9.44
arrow_downward
-0.63%(-0.060) 1D
$9.44
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 13, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLN...
Open
$9.56
High
$9.59
Low
$9.42
Mkt. cap
41.03B
Avg. vol.
19.31M
Volume
13.52M
Dividend
2.10%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
19.72
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.48
Beta
0.16
Shares outstanding
4.40B
No. of employees
25K
Open
$9.56
High
$9.59
Low
$9.42
Mkt. cap
41.03B
Avg. vol.
19.31M
Volume
13.52M
Dividend
2.10%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
19.72
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.48
Beta
0.16
Shares outstanding
4.40B
No. of employees
25K
News stories
From web sources and news partners
AskTraders.com
·
1 day ago
Haleon Shares Rise for a Seventh Straight Session
Stock Traders Daily
·
1 day ago
(HLN) and the Role of Price-Sensitive Allocations
https://www.dars.gov.et/
·
3 days ago
HLN Q4 2024 Earnings: EPS Beats Estimate by 7.2% as Shares Edge Higher - Pre-Announcement Alert
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC - ADR